Clinical Trials Logo

Analgesia, Postoperative clinical trials

View clinical trials related to Analgesia, Postoperative.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03721250 Completed - Clinical trials for Analgesia, Postoperative

Comparison of Thoracic Epidural Analgesia and Intercostal Blockade in Patients Undergoing Thoracotomy

Start date: December 14, 2018
Phase:
Study type: Observational

Postoperative pain is an important issue after thoracotomy operations. Thoracic epidural analgesia is most popular analgesic method, but sometimes it is not sufficient for pain. This study is designed to compare intercostal block with thoracic epidural analgesia in patients undergoing thoracotomy

NCT ID: NCT03541941 Completed - Clinical trials for Analgesia, Postoperative

Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair

Start date: July 3, 2018
Phase: Phase 4
Study type: Interventional

Patients usually experience some level of pain after their hernia repair. To control pain after the operation, surgeons have many options. One of them is to make some injections of pain blocker medications into the nerves that are responsible for the sensations the abdominal wall.This procedure is called TAP block (transversus abdominis place block). These medications are called local anesthetics, and there is a variety of medications that can be used. One of such medications is called Exparel® (Liposomal Bupivacaine). Exparel® has the potential benefit of lasting more hours than regular anesthetics. Although this drug is being used with increasing frequency, the investigators do not have good quality studies investigating the benefits of using this medication during a hernia repair, especially when compared to other types of local anesthetics (Bupivacaine Hydrochloride) or when compared to not injecting this medication at all. This study aim to investigate if Exparel®, when injected in the nerves of the abdominal wall during hernia repair can: (1) reduce the dose of additional opioid medications (morphine and similar) needed to achieve good pain control and (2) result in lower pain scores. The hypothesis is that Exparel® will result in a 30% decrease in the total requirements for opioid medications during the first 72 hours after surgery. Patients will be randomized to receive either Exparel®+Bupivacaine Hydrochloride, Bupivacaine Hydrochloride or Placebo (normal saline) during the operation through a TAP block. All patients will receive a patient controlled analgesia device after the operation, where patients can simply push a button every time they feel pain and the device will administer a dose of opioid medications. The investigators of the study will record the necessary amount of opioids used by the patients to achieve good pain control and also record pain scores several times during hospital stay.

NCT ID: NCT00800826 Completed - Clinical trials for Analgesia, Patient-Controlled

The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia

Start date: November 2006
Phase: Phase 4
Study type: Interventional

This study was designed to examine the analgesic and side effects of dexmedetomidine-morphine mixture for intravenous patient-controlled analgesia (PCA).